Thousand Oaks Biopharmaceuticals Co., Ltd has raised 450 million yuan ($64 million) in a Series B round of financing jointly led by CICC Capital’s sub-fund CICC Jiatai and CITIC Securities’ private equity arm Goldstone Investment Limited.
China Construction Bank’s investment vehicle CCB International, Wens Investment and Shanghai Huaxu Investment also joined the round, the company said in the statement.
